Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Interleukin-2 × 30 days × Clear all

Sponsor

Conditions

Melanoma 4 Ovarian Neoplasms 3 Leukemia, Myeloid, Acute 3 Recurrence 2 Neoplasm Metastasis 2 Lymphoma 2 Leukemia 2 Carcinoma, Non-Small-Cell Lung 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Stomach Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Meningeal Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myeloid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Head and Neck Neoplasms 1

Interventions

pembrolizumab 16 enfortumab vedotin 12 Specimen Handling 9 Magnetic Resonance Spectroscopy 9 Nivolumab 7 Carboplatin 5 avelumab 4 Ipilimumab 4 Gemcitabine 4 Docetaxel 4 Cisplatin 4 sacituzumab govitecan 3 Paclitaxel 3 cabozantinib 2 atezolizumab 2 Taxes 2 CTLA-4 Antigen 2 Biopsy 2 zimberelimab 1 zanidatamab 1 tazemetostat 1 soluble LAG-3 protein, human 1 sargramostim 1 sapanisertib 1 relatlimab 1 regorafenib 1 lenvatinib 1 eribulin 1 erdafitinib 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡